Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-20

Clinical Trial Update: Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating duration of cefazolin and clarithromycin for preterm premature rupture of membranes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFAZOLIN (cefazolin sodium)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Preterm Premature Rupture of Membrane | Phase 3 | Status: COMPLETED